Intervention Review

Calcium antagonists for Duchenne muscular dystrophy

  1. Margaret F Phillips1,*,
  2. Rosaline Quinlivan2

Editorial Group: Cochrane Neuromuscular Group

Published Online: 8 OCT 2008

Assessed as up-to-date: 22 JUL 2010

DOI: 10.1002/14651858.CD004571.pub2

How to Cite

Phillips MF, Quinlivan R. Calcium antagonists for Duchenne muscular dystrophy. Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD004571. DOI: 10.1002/14651858.CD004571.pub2.

Author Information

  1. 1

    University of Nottingham, Division of Rehabilitation Medicine, Derby, UK

  2. 2

    UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery and Great Ormond Street, MRC Centre for Neuromuscular Diseases and Dubowitz Neuromuscular Centre, London, UK

*Margaret F Phillips, Division of Rehabilitation Medicine, University of Nottingham, Dept of Rehabilitation Medicine, Level 2, Royal Derby Hospital, Derby, DE22 3NE, UK.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 8 OCT 2008


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.